4.7 Review

Therapeutic potential of colchicine in cardiovascular medicine: a pharmacological review

期刊

ACTA PHARMACOLOGICA SINICA
卷 43, 期 9, 页码 2173-2190

出版社

NATURE PUBL GROUP
DOI: 10.1038/s41401-021-00835-w

关键词

colchicine; anti-inflammatory drug; cardiovascular diseases; coronary artery disease; atherosclerosis; recurrent pericarditis; restenosis; heart failure; myocardial infarction; cardiovascular complications of COVID-19; microtubules; NF-kappa B; NLRP3 inflammasome

资金

  1. National Natural Science Foundation of China [81941022, 815300254, 82070464]
  2. Anhui Provincial Key Research and Development Program [202104j07020051]
  3. National Key R&D Program of China [2021YFC2500500]
  4. Strategic Priority Research Program of Chinese Academy of Sciences [XDB38010100]
  5. Program for Innovative Research Team of The First Affiliated Hospital of USTC [CXGG02]
  6. Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]
  7. Hefei Comprehensive National Science Center [BJ9100000005]
  8. Hefei Municipal Development and Reform Commission

向作者/读者索取更多资源

Colchicine is an ancient herbal drug with unique anti-inflammatory effects and prominent cardiovascular actions. Clinical trials have confirmed its curative effect in treating cardiovascular diseases, and its anti-inflammatory mechanisms have been studied.
Colchicine is an ancient herbal drug derived from Colchicum autumnale. It was first used to treat familial Mediterranean fever and gout. Based on its unique efficacy as an anti-inflammatory agent, colchicine has been used in the therapy of cardiovascular diseases including coronary artery disease, atherosclerosis, recurrent pericarditis, vascular restenosis, heart failure, and myocardial infarction. More recently, colchicine has also shown therapeutic efficacy in alleviating cardiovascular complications of COVID-19. COLCOT and LoDoCo2 are two milestone clinical trials that confirm the curative effect of long-term administration of colchicine in reducing the incidence of cardiovascular events in patients with coronary artery disease. There is growing interest in studying the anti-inflammatory mechanisms of colchicine. The anti-inflammatory action of colchicine is mediated mainly through inhibiting the assembly of microtubules. At the cellular level, colchicine inhibits the following: (1) endothelial cell dysfunction and inflammation; (2) smooth muscle cell proliferation and migration; (3) macrophage chemotaxis, migration, and adhesion; (4) platelet activation. At the molecular level, colchicine reduces proinflammatory cytokine release and inhibits NF-kappa B signaling and NLRP3 inflammasome activation. In this review, we summarize the current clinical trials with proven curative effect of colchicine in treating cardiovascular diseases. We also systematically discuss the mechanisms of colchicine action in cardiovascular therapeutics. Altogether, colchicine, a bioactive constituent from an ancient medicinal herb, exerts unique anti-inflammatory effects and prominent cardiovascular actions, and will charter a new page in cardiovascular medicine.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据